Seeking Alpha

The FTC ends its investigation into CVS Caremark (CVS +0.5%), settling with the firm for a $5M...

The FTC ends its investigation into CVS Caremark (CVS +0.5%), settling with the firm for a $5M amount on charges it misrepresented Medicare prescription prices at pharmacies. (Complaint .pdf)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector